News

In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...
A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...
Aurivo’s 'charity of the year' initiative has raised €660,000 for a range of non-profits since the charity partner programme ...
Rocky Mountain MS clinic, a Salt Lake City-based provider of specialized care for people living with multiple sclerosis, has ...
Multiple sclerosis sufferer Braylee Burnett, who turns 18 on Wednesday, learned she can once again resume infusions for her ongoing battle after her insurance company previously had balked at more ...
A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. The study may pave the ...
Aubrey LaFon was surrounded with beautiful views. There were gorges and canyons that she ran by. Then she saw plenty of ...
PIP and ADP are tax-free, non-means tested payments that do not affect the benefit cap, which means a single claimant over 25 ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.
An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1 diabetes, hepatitis, ...
One of the most significant immune changes during menopause is an increase in pro-inflammatory cytokines, such as TNF-α and ...